ABL1 and acute lymphoblastic leukemia: A large study of the T-ALL genomic landscape detected 83 chimeric in-frame fusions in 191 patients, of which the most frequently involved were MLLT10, KMT2A, ABL1, and NUP98. The same study found a mean of 15.8 mutations per case in the full cohort of 264 patients.